Literature DB >> 878907

Raynaud's phenomenon. Photoelectric plethysmography of the fingers of persons with and without Raynaud's phenomenon during cooling and warming up.

A A Wouda.   

Abstract

A study has been made of the changes in the amplitudes shown on photoelectric plethysmographs of the fingers of one hand of controls (17 men and 17 women without Raynaud's phenomenon) during cooling and warming up of the hand. This is called the cooling and warming up test. The hands of the women appeared to cool more quickly than of the men, besides getting warm more quickly and remaining warm for a longer period. This difference is already apparent at the lowest water temperatures (6 and 3 degrees C) and may be ascribed to a difference in hand volume, with a hunting reaction due to extreme cold. The lowest values of controls appear to be useful for the clinical differentiation of patients with a serious Raynaud's phenomenon. The test is said to be positive when the values are below the lowest values of the controls. The test was performed on 50 of 58 out-patients suffering from Raynaud's phenomenon. In serious cases the severity of the disease could be assessed objectively. In less serious cases the test was sometimes negative.

Entities:  

Mesh:

Year:  1977        PMID: 878907

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  10 in total

1.  Once daily felodipine in patients with primary Raynaud's phenomenon.

Authors:  C G Kallenberg; A A Wouda; L Meems; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Connective tissue disease in patients presenting with Raynaud's phenomenon alone.

Authors:  C G Kallenberg
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

3.  Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular disease.

Authors:  E van der Veur; B S ten Berge; A A Wouda; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Sublingual and oral isoxsuprine in patients with Raynaud's phenomenon.

Authors:  H Wesseling; A den Heeten; A A Wouda
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease?

Authors:  P M Houtman; C G Kallenberg; A A Wouda; T H The
Journal:  Ann Rheum Dis       Date:  1985-09       Impact factor: 19.103

6.  Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.

Authors:  C G Kallenberg; A A Wouda; M H Hoet; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

7.  Prostaglandin E1 vasospastic disease and thermography.

Authors:  V Kyle; G Parr; R Salisbury; P P Thomas; B Hazleman
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

8.  Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenon.

Authors:  J van der Maulen; A A Wouda; E Mandema; T H The
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

9.  Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.

Authors:  C G Kallenberg; G W Pastoor; A A Wouda; T H The
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

10.  No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis.

Authors:  Martha E Hettema; Dan Zhang; Ymkje Stienstra; Andries J Smit; Hendrika Bootsma; Cees G M Kallenberg
Journal:  Clin Rheumatol       Date:  2009-04-07       Impact factor: 2.980

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.